Data |
Ora |
Fonte |
Titolo |
11/3/2025 | 22:06 | EDGAR2 | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
11/3/2025 | 15:00 | EDGAR2 | Form 8-K - Current report |
11/3/2025 | 13:00 | GLOBE | Nuwellis, Inc. Announces Fourth Quarter and Full Year 2024.. |
24/2/2025 | 22:05 | GLOBE | Nuwellis Announces Retirement of Nestor Jaramillo, Jr. as.. |
20/2/2025 | 14:00 | GLOBE | JACC: Heart Failure Paper Reports Promising Findings of.. |
18/2/2025 | 22:15 | GLOBE | Nuwellis, Inc. To Report Fourth Quarter and Full Year 2024.. |
13/1/2025 | 14:00 | GLOBE | Nuwellis Adds Nationally Ranked Utah Hospital as New.. |
19/12/2024 | 15:00 | GLOBE | Nuwellis Regains Compliance with Nasdaq Listing Requirements |
20/11/2024 | 19:29 | EDGAR2 | Form D - Notice of Exempt Offering of Securities |
11/11/2024 | 14:00 | GLOBE | Nuwellis, Inc. Announces Third Quarter 2024 Financial.. |
11/11/2024 | 12:04 | IHMARKETNEWS | Tesla Rises 5% Pre-Market After Surpassing $1T Market Value;.. |
05/11/2024 | 15:28 | GLOBE | Nuwellis Announces Exercise of Warrants for $5.1 Million of.. |
04/11/2024 | 14:30 | GLOBE | Nuwellis Receives Increased Reimbursement Rate for Aquadex.. |
01/11/2024 | 21:15 | GLOBE | Nuwellis Announces Preliminary Results for Third Quarter of.. |
31/10/2024 | 13:00 | GLOBE | Nuwellis Welcomes University of Iowa Health Care Stead.. |
23/10/2024 | 22:15 | GLOBE | Nuwellis, Inc. To Report Third Quarter 2024 Financial.. |
25/9/2024 | 22:15 | GLOBE | Nuwellis to Present at the Third Annual ROTH Healthcare.. |
30/8/2024 | 22:11 | EDGAR2 | Form SC 13G - Statement of Beneficial Ownership by Certain.. |
27/8/2024 | 15:00 | GLOBE | New Study Published in Current Problems in Cardiology.. |
26/8/2024 | 22:45 | EDGAR2 | Form 8-K - Current report |
24/8/2024 | 03:31 | EDGAR2 | Form 424B5 - Prospectus [Rule 424(b)(5)] |
23/8/2024 | 15:00 | GLOBE | Nuwellis Announces Pricing of $916,000 Registered Direct.. |
13/8/2024 | 23:10 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
13/8/2024 | 19:00 | EDGAR2 | Form 8-K - Current report |
13/8/2024 | 14:00 | GLOBE | Nuwellis, Inc. Announces Second Quarter 2024 Financial.. |
12/8/2024 | 15:15 | EDGAR2 | Form 8-K - Current report |
08/8/2024 | 15:00 | GLOBE | Nasdaq Panel Grants Nuwellis Continued Listing on the Nasdaq.. |
02/8/2024 | 22:12 | EDGAR2 | Form SC 13G - Statement of Beneficial Ownership by Certain.. |
26/7/2024 | 15:00 | GLOBE | Nuwellis Announces First Pediatric Patient Treated in a.. |
25/7/2024 | 15:25 | EDGAR2 | Form 424B5 - Prospectus [Rule 424(b)(5)] |
25/7/2024 | 14:31 | EDGAR2 | Form 8-K - Current report |
24/7/2024 | 14:02 | GLOBE | Nuwellis Announces Pricing of $2.0 Million Offering Priced.. |
23/7/2024 | 22:10 | GLOBE | Nuwellis, Inc. To Report Second Quarter 2024 Financial.. |
17/7/2024 | 22:01 | EDGAR2 | Form 8-K/A - Current report: [Amend] |
17/7/2024 | 15:12 | EDGAR2 | Form 8-K - Current report |
17/7/2024 | 15:00 | GLOBE | Nuwellis Marks First Commercial Sale of QUELIMMUNE™ Therapy.. |
12/7/2024 | 14:30 | GLOBE | SeaStar Medical Ships First QUELIMMUNE Product Order to U.S... |
09/7/2024 | 15:00 | GLOBE | New Evidence on Aquadex Ultrafiltration Therapy to be.. |
26/6/2024 | 14:45 | GLOBE | Nuwellis Announces Reverse Stock Split |
25/6/2024 | 15:00 | GLOBE | Nuwellis Secures New Patent for Innovative Pediatric.. |
10/6/2024 | 22:15 | EDGAR2 | Form 8-K - Current report |
06/6/2024 | 15:15 | EDGAR2 | Form 8-K - Current report |
06/6/2024 | 15:00 | GLOBE | Nuwellis and DaVita Extend Supply and Collaboration.. |
29/5/2024 | 17:54 | EDGAR2 | Form SD - Specialized disclosure report |
17/5/2024 | 23:20 | EDGAR2 | Form DEFR14A - Revised definitive proxy soliciting materials |
14/5/2024 | 15:00 | GLOBE | Nuwellis Announces Expansion of Ultrafiltration Program to.. |
09/5/2024 | 15:00 | GLOBE | Nuwellis Announces Purchase Agreement with a 50 Hospital.. |
08/5/2024 | 23:28 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
08/5/2024 | 23:26 | EDGAR2 | Form PRER14A - Preliminary Proxy Soliciting materials |
07/5/2024 | 14:00 | GLOBE | Nuwellis, Inc. Announces First Quarter 2024 Financial.. |